ARCHIVES

Solomon Garb’s Questions/Answers

This article is from The Cancer Letter archive.

Vol. 07 No. 02 | January 9, 1981

Download PDF Visit The Full Archive

Related Articles

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

IVAX And It’s Portfolio

December 22, 1994

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002